A group of cancer genetics researchers in Italy and the U.S. has retracted three papers in the Journal of Biological Chemistry (JBC) after it became aware they had duplicated some bands in their figures.
Here are the three papers: Continue reading Cancer genetics group retracts three papers for “inappropriate presentation of data”
Melanie Pallansch-Cokonis, a former research technician at Southern Research Institute, faked data in work funded by NIH contracts and grants, according to the Office of Research Integrity (ORI).
According to the ORI’s case summary, available today in the Federal Register: Continue reading Research technician faked NIH-funded research: ORI
Dong Pyou-Han, a former researcher at Iowa State University who spiked rabbit blood samples to make it look as though a potential HIV vaccine was working, was arrested earlier this week on felony charges.
According to the Des Moines Register: Continue reading Unusual: HIV vaccine researcher who faked data arrested, faces felony charges
Check List, the “journal of species lists and distribution,” retracted a paper in February after the authors realized they hadn’t spotted a yellow-red rat snake in a strange range, but rather a green rat snake in its known home.
Here’s the notice for “New distribution and elevation records for the snake Pseudelaphe flavirufa Cope, 1867 (Squamata: Colubridae) in Oaxaca, Mexico,” as written by the authors: Continue reading Rats! Snake mistake sinks paper
The journal Blood has retracted a 2010 paper over the objections of most of its authors, two of whom were found by their university to have used “fraudulent methods” to obtain the data.
We first reported on the case of Gerold Feuer last fall. The State University of New York (SUNY) Upstate Medical Center in Syracuse fired Feuer in 2010 after determining that he had misused state funds to enrich a company he had founded, HuMurine. A court agreed with many of the university’s claims, but ordered his reinstatement in 2012.
Meanwhile, as we noted last fall: Continue reading Journal retracts stem cell study despite objections of most authors
A group of physicists has retracted their preliminary report in the GCN Circular of a massive star-sized explosion after deciding that what they’d really observed was another phenomenon.
Although we could try to explain this, we’d rather leave it up to Giacomo Vianello, an experimental physicist at Stanford University, who was a member of the research team.
Vianello told us: Continue reading Twinkle, twinkle little star, how I wonder where you went: Astronomy report retracted
Pfizer has retracted another study involving an experimental cancer drug that later failed later-stage trials.
The study, published in Clinical Cancer Research in 2010, looked at which patients might respond to the drug, called figitumumab. Here’s the notice: Continue reading Pfizer retracts another experimental cancer drug study
Oncology Reviews has retracted a 2014 paper on breast cancer after learning that the authors lifted parts of it from a continuing medical education lesson on Medscape.
The paper, “Challenges of combined everolimus/endocrine therapy in hormone receptor-positive metastatic breast cancer,” was written by Yousif Abubakr, of Thomas Jefferson University in Philadelphia, and Yasar Albushra, of King Faisal Specialist Hospital & Research Centre, in Saudi Arabia.
According to the retraction notice: Continue reading Authors plagiarize CME cancer article, lose their review paper
The authors of a Current Biology paper published online in February of this year have retracted it after voluminous criticism on post-publication review site PubPeer and a university committee found evidence of figure manipulation.
The paper, “Agonist-Induced GPCR Shedding from the Ciliary Surface Is Dependent on ESCRT-III and VPS4,” was co-authored by Hua Jin and Livana Soetedjo, a graduate student in Jin’s lab. Soetedjo was first author, and Jin was corresponding author.
The comments at PubPeer began on March 24: Continue reading Authors retract Current Biology study following criticism on PubPeer and university investigation
We recently came across a paper in Biochemical and Biophysical Research Communications, an Elsevier title, that had been temporarily removed without explanation. While we see a fair number of such opaque notices from Elsevier — and have written about why we think they’re a bad idea — we took interest in this one because the last author, Toren Finkel of the NIH, was the corresponding author of a Nature paper retracted earlier this year. (He also had two corrections on one Science paper, both of which are paywalled.)
What we learned suggests the withdrawal was completely unrelated to the Nature retraction, but also reveals a journal editor’s exasperation.